Phase II Study of AVX/COVID-12 Vaccine in Subjects With Prior SARS-CoV-2 Immunity Evidence
Clinical trial NCT05205746 · COMPLETED
Trial details
- NCT number
- NCT05205746
- Sponsor
- Laboratorio Avi-Mex, S.A. de C.V.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-23
- Primary completion
- 2022-08-09
- Enrollment
- 158
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.